Skip to content
Sarah Gilbert

Image by Flybynight on Pixabay · Pixabay License

EntityQ30513802· pop 32· linked from 1,419 articles

Sarah Gilbert

Sign in to save

Also known as Sarah C. Gilbert, Sarah C Gilbert, S. C. Gilbert, S C Gilbert, S. Gilbert, S Gilbert, Gilbert, Gilbert S

British vaccinologist

Person · Open Library

Works
27

Top works

  • Lonely Planet Costa Rica
  • Makeup Like a Pro
  • Eye Shadow Techniques
  • Tale of My Tail
  • Hello, at Last

via Open Library + Wikidata

Music · MusicBrainz

Type
Person
Gender
Male
Origin
England
Active from
1836-11-18
Active to
1911-05-29

via MusicBrainz · CC0

Listeners · Last.fm

Listeners
4
Total plays
122

<a href="https://www.last.fm/music/Sarah+Gilbert">Read more on Last.fm</a>

via Last.fm · Sarah Gilbert

Quotes

  • I have worked in the development of vaccines against infectious pathogens for many years and in the last 2 years have been able to draw on all that I have learned in order to respond to the SARS-CoV-2 pandemic. I have been so fortunate to work with a very talented and dedicated team who made it possible to develop a vaccine in less time than anyone thought possible.

via Wikiquote · CC BY-SA

Key facts

Born
April 1962 (age 64), Kettering, Northamptonshire , England
Alma mater
University of East Anglia (BSc), University of Hull (PhD)
Known for
Vaccinology
Awards
Albert Medal (2021), Princess of Asturias Award (2021), King Faisal Prize (2023)
Fields
Vaccines
Institutions
University of Oxford , Vaccitech , Delta Biotechnology, Leicester Biocentre, Brewing Industry Research Foundation , Christ Church, Oxford
Thesis
Studies on lipid accumulation and genetics of Rhodosporidium toruloides (1986)
Doctoral advisor
Colin Ratledge , Dr M. Keenan
Website
www .jenner .ac .uk /team /sarah-gilbert

via Wikipedia infobox

~13 min read

Encyclopedic overview

Dame Sarah Catherine Gilbert (born April 1962) is an English vaccinologist who is a Professor of Vaccinology at the University of Oxford and co-founder of Vaccitech. She specialises in the development of vaccines against influenza and emerging viral pathogens. She led the development and testing of the universal flu vaccine, which underwent clinical trials in 2011.

In January 2020, she read a report on ProMED-mail about four people in China suffering from a strange kind of pneumonia of unknown origin in Wuhan. Within two weeks, a vaccine had been designed at Oxford against the new pathogen, which later became known as COVID-19. On 30 December 2020, the Oxford–AstraZeneca COVID-19 vaccine she co-developed with the Oxford Vaccine Group was approved for use in the UK. More than 3 billion doses of the vaccine were supplied to countries worldwide.

Excerpted from Wikipedia’s “Sarah Gilbert” article, available under the CC BY-SA 4.0 licence.